Brain MRI atrophy quantification in MS: From methods to clinical application.
Patients with the main clinical phenotypes of multiple sclerosis (MS) manifest varying degrees of brain atrophy beyond that of normal aging. Assessment of atrophy helps to distinguish clinically and cognitively deteriorating patients and predicts those who will have a less-favorable clinical outcome...
Asıl Yazarlar: | Rocca, M, Battaglini, M, Benedict, R, De Stefano, N, Geurts, J, Henry, R, Horsfield, M, Jenkinson, M, Pagani, E, Filippi, M |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
American Academy of Neurology
2016
|
Benzer Materyaller
-
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
Yazar:: Houshang Amiri, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01) -
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
Yazar:: Vrenken, H, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
Yazar:: Vrenken, H, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy
Yazar:: Theodoros Ladopoulos, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01) -
Measurement of whole-brain and gray matter atrophy in multiple sclerosis: assessment with MR imaging
Yazar:: Storelli, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)